Semaglutide , a GLP-1 receptor agonist, works by mimicking the natural hormone GLP-1, which plays a key role in regulating appetite and satiety
Meaning they're created to have a certain purity and composition, and then, all medications have some fillers in them
That means: * We cant yet predict *who* will respond best * Optimal dosing for MCAS is still unknown * These medications are often used off-label for MCAS * Cost and access remain real barriers That said, the authors strongly emphasize something important: many MCAS patients responded to much lower doses than those typically prescribed for diabetes or obesity, which may improve tolerability and safety
The insulinotropic effects of tirzepatide are glucose-dependent, meaning they activate when blood glucose is elevated, providing rapid benefit
Regular review with diabetes specialist teams ensures treatment remains aligned with individual needs, tolerability, and glycaemic targets whilst maintaining quality of life
Many patients prescribed metformin for type 2 diabetes or polycystic ovary syndrome (PCOS) consider adding berberine, a plant-derived supplement with purported glucose-lowering properties